Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Constitutional mismatch repair deficiency syndrome with atypical features caused by a homozygous MLH1 missense variant (c.1918C>A, p.(Pro640Thr)): a case report. | Front Oncol | 2023 | 37664053 | PubTator, text mining | PubMed |
| Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel. | PLoS One | 2023 | 37656691 | PubTator, text mining | PubMed |
| Diagnosis and Surgical Management of Insulinomas-A 23-Year Single-Center Experience. | Medicina (Kaunas) | 2023 | 37629713 | PubTator, text mining | PubMed |
| Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary Breast and Colorectal Cancer Patients. | Genes (Basel) | 2023 | 37628631 | PubTator, text mining | PubMed |
| Impact of High-to-Moderate Penetrance Genes on Genetic Testing: Looking over Breast Cancer. | Genes (Basel) | 2023 | 37628581 | PubTator, text mining | PubMed |
| Melatonin Improves Skeletal Muscle Structure and Oxidative Phenotype by Regulating Mitochondrial Dynamics and Autophagy in Zücker Diabetic Fatty Rat. | Antioxidants (Basel) | 2023 | 37627494 | PubTator, text mining | PubMed |
| Understanding DNA Damage Response and DNA Repair in Multiple Myeloma. | Cancers (Basel) | 2023 | 37627183 | PubTator, text mining | PubMed |
| Variant Characterization of a Representative Large Pedigree Suggests "Variant Risk Clusters" Convey Varying Predisposition of Risk to Lynch Syndrome. | Cancers (Basel) | 2023 | 37627102 | PubTator, text mining | PubMed |
| Cancer Predisposition Syndromes and Thyroid Cancer: Keys for a Short Two-Way Street. | Biomedicines | 2023 | 37626640 | PubTator, text mining | PubMed |
| A novel pathogenic frameshift variant in AXIN2 in a man with polyposis and hypodontia. | Hered Cancer Clin Pract | 2023 | 37626374 | PubTator, text mining | PubMed |
| Dual CRISPR-Cas3 system for inducing multi-exon skipping in DMD patient-derived iPSCs. | Stem Cell Reports | 2023 | 37625413 | PubTator, text mining | PubMed |
| The Spectrum of Germline Nucleotide Variants in Gastric Cancer Patients in the Kyrgyz Republic. | Curr Issues Mol Biol | 2023 | 37623222 | PubTator, text mining | PubMed |
| An Overview of Pancreatic Neuroendocrine Tumors and an Update on Endoscopic Techniques for Their Management. | Curr Oncol | 2023 | 37623030 | PubTator, text mining | PubMed |
| An overview on the relationship between residential radon and lung cancer: what we know and future research. | Clin Transl Oncol | 2023 | 37610496 | PubTator, text mining | PubMed |
| Refining a Multifaceted Model of Perceived Utility of Genomic Sequencing Results. | Public Health Genomics | 2023 | 37607497 | PubTator, text mining | PubMed |
| ATM-Inhibitor AZD1390 Is a Radiosensitizer for Breast Cancer CNS Metastasis. | Clin Cancer Res | 2023 | 37585496 | PubTator, text mining | PubMed |
| Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs. | Oncogene | 2023 | 37573406 | PubTator, text mining | PubMed |
| Mutational Signatures in Gastric Cancer and Their Clinical Implications. | Cancers (Basel) | 2023 | 37568604 | PubTator, text mining | PubMed |
| Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions. | Cancers (Basel) | 2023 | 37568572 | PubTator, text mining | PubMed |
| Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing. | NPJ Precis Oncol | 2023 | 37568048 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=19